These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 38480712)

  • 1. Ferroptosis: a new hunter of hepatocellular carcinoma.
    Jiang Y; Yu Y; Pan Z; Glandorff C; Sun M
    Cell Death Discov; 2024 Mar; 10(1):136. PubMed ID: 38480712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Targets of Ferroptosis in Hepatocellular Carcinoma.
    Liao H; Shi J; Wen K; Lin J; Liu Q; Shi B; Yan Y; Xiao Z
    J Hepatocell Carcinoma; 2021; 8():985-996. PubMed ID: 34466409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma.
    Huang Z; Xia H; Cui Y; Yam JWP; Xu Y
    J Clin Transl Hepatol; 2023 Feb; 11(1):207-218. PubMed ID: 36406319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma.
    Li L; Wang X; Xu H; Liu X; Xu K
    Front Mol Biosci; 2022; 9():947208. PubMed ID: 36052168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis: a new promising target for hepatocellular carcinoma therapy.
    Xu Q; Ren L; Ren N; Yang Y; Pan J; Zheng Y; Wang G
    Mol Cell Biochem; 2023 Dec; ():. PubMed ID: 38051404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma.
    Lu Y; Chan YT; Tan HY; Zhang C; Guo W; Xu Y; Sharma R; Chen ZS; Zheng YC; Wang N; Feng Y
    J Exp Clin Cancer Res; 2022 Jan; 41(1):3. PubMed ID: 34980204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate Modification Promotes Intestinal Absorption and Hepatic Cancer Cells Targeting of Ferroptosis Inducer Loaded Nanoparticle for Enhanced Hepatocellular Carcinoma Therapy.
    Yu Y; Shen X; Xiao X; Li L; Huang Y
    Small; 2023 Sep; 19(36):e2301149. PubMed ID: 37165608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA CASC11 suppresses sorafenib-triggered ferroptosis via stabilizing SLC7A11 mRNA in hepatocellular carcinoma cells.
    Chen F; Wang L
    Discov Oncol; 2023 Aug; 14(1):145. PubMed ID: 37552314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Activation of YAP Signaling Sensitizes Ferroptosis of Hepatocellular Carcinoma
    Qin Y; Pei Z; Feng Z; Lin P; Wang S; Li Y; Huo F; Wang Q; Wang Z; Chen ZN; Wu J; Wang YF
    Front Cell Dev Biol; 2021; 9():751593. PubMed ID: 34977009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib.
    Louandre C; Ezzoukhry Z; Godin C; Barbare JC; Mazière JC; Chauffert B; Galmiche A
    Int J Cancer; 2013 Oct; 133(7):1732-42. PubMed ID: 23505071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Insights in the Regulatory Mechanisms of Ferroptosis in Hepatocellular Carcinoma.
    Ma S; Adzavon YM; Wen X; Zhao P; Xie F; Liu M; Ma X
    Front Cell Dev Biol; 2022; 10():873029. PubMed ID: 35663406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma.
    Zhao S; Zheng W; Yu C; Xu G; Zhang X; Pan C; Feng Y; Yang K; Zhou J; Ma Y
    Front Cell Dev Biol; 2022; 10():845232. PubMed ID: 35309918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CRISPR-Cas9 library screening identifies CARM1 as a critical inhibitor of ferroptosis in hepatocellular carcinoma cells.
    Cheng Y; Wang X; Huang S; Zhang L; Lan B; Li X; Chen H; Liu Z; Su Y; Xi L; Feng S; Guo Y; Zhou J; Wang Y; Xuan C
    Mol Ther Nucleic Acids; 2023 Dec; 34():102063. PubMed ID: 38028203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-1-mediated MET/AXL signaling enhances sorafenib resistance in hepatocellular carcinoma by escaping ferroptosis.
    Hsu TW; Su YH; Chen HA; Liao PH; Shen SC; Tsai KY; Wang TH; Chen A; Huang CY; Shibu MA; Wang WY; Shen SC
    Aging (Albany NY); 2023 Jul; 15(13):6503-6525. PubMed ID: 37433225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma.
    Li B; Wei S; Yang L; Peng X; Ma Y; Wu B; Fan Q; Yang S; Li X; Jin H; Tang S; Huang M; Li H; Liu J
    Front Oncol; 2021; 11():657723. PubMed ID: 34485112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation.
    Bekric D; Ocker M; Mayr C; Stintzing S; Ritter M; Kiesslich T; Neureiter D
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma.
    Wang Z; Zhou C; Zhang Y; Tian X; Wang H; Wu J; Jiang S
    Biomed Pharmacother; 2024 Jan; 170():116074. PubMed ID: 38147732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
    Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
    Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ferroptosis in hepatocellular carcinoma.
    Nie J; Lin B; Zhou M; Wu L; Zheng T
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2329-2337. PubMed ID: 30167889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma.
    Zhang L; Li XM; Shi XH; Ye K; Fu XL; Wang X; Guo SM; Ma JQ; Xu FF; Sun HM; Li QQ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2023 Mar; 44(3):622-634. PubMed ID: 36109580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.